Recursion Pharmaceuticals, Inc. ( RXRX) - Key Metrics
RXRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.07 | -$0.21 | -$0.09 | -$0.09 |
| 2025Q3 | $0.01 | -$0.36 | -$0.26 | -$0.26 |
| 2025Q2 | $0.05 | -$0.41 | -$0.18 | -$0.19 |
| 2025Q1 | $0.04 | -$0.50 | -$0.33 | -$0.33 |
RXRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -4.98 |
| 2025Q3 | ? | -3.36 |
| 2025Q2 | ? | -3.07 |
| 2025Q1 | ? | -2.63 |
RXRX
Price: $3.29
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 732400
Market Capitalization: 1.5 billion